CD274 and neoplasm: No correlation was found for preneoadjuvant treatment PD-L1 TPS categorized into <1%, 1%-49%, and ≥50% with tumor downstaging after neoadjuvant therapy (TNM downstaging versus no downstaging; Supplementary Table S5, available at https://doi.org/10.1016/j.esmoop.2023.101595).